ReviewJournal of inflammation research2026
Inflammatory and Regenerative Signalling in Traditional Chinese Medicine Debridement-Granulation Therapy for Chronic Wounds: A Narrative Review.
Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic non‑healing wounds bring substantial clinical and socioeconomic burdens worldwide. Traditional Chinese medicine (TCM) debridement‑granulation therapy (original therapeutic principle: Qufu Shengji, defined as removing necrotic tissue to stimulate granulation growth) represents a classic topical therapeutic concept for refractory cutaneous ulcers. As a narrative review rather than a pre‑registered systematic review, this work qualitatively integrates publicly available pre‑clinical experimental findings from isolated herbal monomers, compound formulas and topical preparations guided by debridement‑granulation principles. We elaborate their stage‑specific regulatory effects on core signaling cascades corresponding to debridement‑stage and granulation‑formation‑stage processes. It should be noted that almost all mechanistic observations are derived from pre‑clinical cell and animal experiments, and further clinical validation based on human wound samples is urgently required. During the debridement stage, TCM‑derived agents suppress persistent inflammatory cascades by inhibiting NF‑κB, JAK2/STAT3, AGEs‑RAGE and NLRP3/Caspase‑1/Gasdermin‑D pathways, facilitating necrotic tissue clearance and M1‑to‑M2 macrophage phenotypic transformation. During the granulation‑promoting stage, such herbal preparations activate PI3K/Akt, Nrf2/ARE, Wnt/β‑catenin and cAMP/PKA signaling pathways to promote fibroblast proliferation, angiogenesis, collagen deposition and epidermal re‑epithelialization. This review further objectively analyses major limitations within existing pre‑clinical research, including oversimplified animal models, unclear pharmacodynamic material basis of compound prescriptions, insufficient exploration of signaling‑pathway crosstalk, heterogeneous experimental protocols, publication bias and limited safety data for topical TCM preparations. Targeted directions for subsequent mechanistic exploration, novel transdermal‑preparation development and translational clinical verification are proposed. This two‑stage conceptual framework aims to provide theoretical references for future mechanistic and translational studies for TCM wound care, rather than confirming definite clinical therapeutic efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.